Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy

BACKGROUND: New treatment options are needed to maintain and improve therapy for tuberculosis, which caused the death of 1.5 million people in 2013 despite potential for an 86 % treatment success rate. A greater understanding of Mycobacterium tuberculosis (M.tb) bacilli that persist through drug the...

Descripción completa

Detalles Bibliográficos
Autores principales: Honeyborne, Isobella, McHugh, Timothy D., Kuittinen, Iitu, Cichonska, Anna, Evangelopoulos, Dimitrios, Ronacher, Katharina, van Helden, Paul D., Gillespie, Stephen H., Fernandez-Reyes, Delmiro, Walzl, Gerhard, Rousu, Juho, Butcher, Philip D., Waddell, Simon J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825072/
https://www.ncbi.nlm.nih.gov/pubmed/27055815
http://dx.doi.org/10.1186/s12916-016-0609-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825072/
https://www.ncbi.nlm.nih.gov/pubmed/27055815
http://dx.doi.org/10.1186/s12916-016-0609-3

Ejemplares similares